Banka BioLoo working capital

·UnclassifiedChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
155.46×155.46×161.05×190.89×574.72×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
182.05×182.05×171.00×126.54×100.84×
174.99×174.99×107.23×79.50×207.32×
162.52×162.52×224.82×237.93×468.24×
2.28×2.30×3.53×2.08×1.85×
0.62×0.62×0.68×0.70×0.65×
2.68×2.68×−0.10×−4.15×3.77×
0.20×0.20×−0.30×0.77×1.61×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BANKA₹62.50

Banka BioLoo Limited

· Unclassified
₹ CrorePeersRAJMETAAKASHGLOBEGRADIENTEMOKSHARTNIRMANAJOONIBEARDSELLMcap ₹68.3 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)574.72190.89161.05155.46155.46
Receivable Days (DSO)100.84126.54171.00182.05182.05
Payable Days (DPO)207.3279.50107.23174.99174.99
Cash Conversion Cycle (days)468.24237.93224.82162.52162.52
Working Capital Turnover1.852.083.532.302.28
Asset Turnover0.650.700.680.620.62
Cash Conversion (CFO/Net Income)3.77-4.15-0.102.682.68
CFO/EBITDA1.610.77-0.300.200.20
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.